These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 4578564

  • 41. Progressing Moloney sarcoma virus (M-MSV) induced tumors: effect of host's immunomanipulation.
    Collavo D, Zanovello P, Biasi G, Chieco-Bianchi L.
    Cell Mol Biol Incl Cyto Enzymol; 1980; 26(2):155-8. PubMed ID: 6970620
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. [Genetic control of murine leukemias induced by Moloney virus].
    Debré P, Gisselbrecht S, Boyer B, Lévy JP.
    Bull Cancer; 1982; 69(2):178-87. PubMed ID: 6812667
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Proceedings: "Wild" type antigens of sarcomata induced by a natural amine sarcoma virus (MSV-FBJ).
    Jones DB, Moore M.
    Br J Cancer; 1974 Jan; 29(1):94-5. PubMed ID: 4595171
    [No Abstract] [Full Text] [Related]

  • 47. Anemia virus as a distinct component of the murine leukemia-sarcoma complex of viruses.
    Siegler R, Lane I, Moran S, Leavitt P.
    Cancer Res; 1973 Aug; 33(8):1858-61. PubMed ID: 4352740
    [No Abstract] [Full Text] [Related]

  • 48. Studies on Murine Sarcoma Virus: antigenic characterization of Murine Sarcoma Virus induced tumor cells.
    Chuat JC, Berman L, Gunvén P, Klein E.
    Int J Cancer; 1969 Jul 15; 4(4):465-79. PubMed ID: 4899685
    [No Abstract] [Full Text] [Related]

  • 49. T lymphocyte requirement for MSV tumour prevention or regression.
    Collavo D, Colombatti A, Chieco-Bianchi L.
    Nature; 1974 May 10; 249(453):169-70. PubMed ID: 4545519
    [No Abstract] [Full Text] [Related]

  • 50. Studies on immunity to autochthonous mouse tumors.
    Hellström I, Hellström KE, Pierce GE, Fefer A.
    Transplant Proc; 1969 Mar 10; 1(1):90-4. PubMed ID: 5406848
    [No Abstract] [Full Text] [Related]

  • 51. Immunotherapy of a murine leukemia virus-infected, chemically induced murine sarcoma with antiviral antibodies.
    Ward EC, Iglehart JD, Weinhold KJ, Bolognesi DP.
    J Natl Cancer Inst; 1982 Aug 10; 69(2):509-15. PubMed ID: 6955550
    [Abstract] [Full Text] [Related]

  • 52. Prolongation of chemotherapeutically induced remission of a syneneic murine leukemia by L-2,3,5,6-tetrahydro-6-phenylimidazo[2.1-BETA]thiazole hydrochloride.
    Chirigos MA, Fuhrman F, Pryor J.
    Cancer Res; 1975 Apr 10; 35(4):927-31. PubMed ID: 1116150
    [Abstract] [Full Text] [Related]

  • 53. Antigenic properties of a nonreleaser neoplasm induced in the mouse by murine sarcoma virus.
    Law LW, Ting RC.
    J Natl Cancer Inst; 1970 Mar 10; 44(3):615-21. PubMed ID: 11515430
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. The pathology of tumors and other lesions induced in rodents by virus derived from a rat with Moloney leukemia.
    Chesterman FC, Harvey JJ, Dourmashkin RR, Salaman MH.
    Cancer Res; 1966 Aug 10; 26(8):1759-68. PubMed ID: 5923174
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.